Search

PerkinElmer Inc

Fechado

SetorSaúde

0

Visão Geral

Variação de preço das ações

24h

Atual

Mín

Máximo

Indicadores-chave

By Trading Economics

Rendimento

13M

53M

Vendas

19M

730M

P/E

Médio do Setor

76.742

50.373

EPS

1.41

Rendimento de Dividendos

0.18

Margem de lucro

7.329

Funcionários

11,000

EBITDA

8.8M

189M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

-14.26% downside

Dividendos

By Acuity

Rendimento de Dividendos

Médio do Setor

0.18%

2.12%

Próximos Ganhos

3 de nov. de 2026

Próxima data de dividendos

13 de nov. de 2026

Próxima data de ex-dividendo

15 de jan. de 2027

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

5B

18B

Abertura anterior

0

Fecho anterior

0

PerkinElmer Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

28 de out. de 2026, 20:06 UTC

Correlated Moves

Revvity, Inc. shares are advancing, continuing an upward trend since Tuesday, despite earlier pulling back from a session high, remaining above its 20-day moving average.

26 de out. de 2026, 19:16 UTC

Revvity Inc shares are advancing, continuing a trend of modest gains since Friday's close, despite an earlier pullback from a session high.

23 de out. de 2026, 20:13 UTC

Revvity Inc shares are trading modestly higher in after-market hours, continuing a trend of five consecutive sessions finishing higher.

22 de out. de 2026, 21:41 UTC

Revvity Inc shares have declined in after-market trading, reaching their lowest point of the day after moving from a slight loss post-close.

21 de out. de 2026, 20:07 UTC

Correlated Moves

Revvity Inc shares are advancing, continuing an upward trend since Tuesday, while Charles River Laboratories is sharply higher with increased trading activity and volume.

20 de out. de 2026, 20:02 UTC

News

Revvity Inc. launches its AI-first Signals LabGistics solution to streamline scientific workflows in pharma and biotech, with positive outlook from Citrini Research.

19 de out. de 2026, 19:36 UTC

Correlated Moves

Revvity Inc shares are declining, facing speculation around Thermo Fisher Scientific Inc's upcoming earnings report, despite earlier reaching a session high.

16 de out. de 2026, 21:02 UTC

Revvity Inc's shares are declining in after-market trading, hitting their lowest level since Friday's close amid ongoing price weakness.

15 de out. de 2026, 23:46 UTC

Revvity Inc's shares declined modestly in after-market trading, following earlier gains, and remain near the upper end of their one-month range.

14 de out. de 2026, 23:46 UTC

Revvity Inc shares are trading modestly lower in after-market hours, continuing a decline that began after Wednesday's close.

13 de out. de 2026, 20:13 UTC

Revvity Inc shares are trading modestly lower in after-market hours, continuing a downward trend since Tuesday's close amid unusual weakness during the session.

12 de out. de 2026, 19:51 UTC

Revvity Inc shares are advancing, continuing a higher trend since Friday's close, despite currently trading lower in today's session.

8 de out. de 2026, 20:06 UTC

Revvity Inc shares are declining, having pulled back from earlier gains amid a broader market trend lower since Wednesday's close.

7 de out. de 2026, 19:25 UTC

News

Barclays raised Revvity Inc's price target to $160.00 from $115.00, maintaining an Equal-weight rating, as the stock trades modestly higher.

6 de out. de 2026, 22:41 UTC

News

Revvity Inc shares declined in after-market trading despite an Outperform rating from William Blair, closing at their lowest point since Tuesday.

5 de out. de 2026, 19:21 UTC

Correlated Moves

Revvity Inc is advancing, likely influenced by a significant rise in shares of Charles River Laboratories, reaching its best cumulative return since Friday's close.

2 de out. de 2026, 19:45 UTC

News

Revvity Inc. will release Q3 2026 financial results on November 3, 2026, contributing to the stock's upward movement today, despite a slight retracement.

1 de out. de 2026, 20:03 UTC

Revvity Inc shares fell sharply from an early peak, currently trading near their lowest point of the day despite being above the 20-day moving average.

30 de set. de 2026, 21:02 UTC

Revvity Inc is trading modestly higher in after-market hours, significantly above its 20-day moving average and near the upper end of its one-month range.

29 de set. de 2026, 19:36 UTC

Revvity Inc is trading higher, reaching a peak return since Monday's close and maintaining a position above its 20-day moving average.

28 de set. de 2026, 20:20 UTC

Revvity Inc's shares are trading modestly lower in after-market hours, shifting from a slight gain to a loss since Monday's close.

25 de set. de 2026, 20:01 UTC

Revvity Inc shares fell sharply, pulling back from earlier gains and currently trading below Thursday's close despite being above its 20-day moving average.

24 de set. de 2026, 23:11 UTC

Revvity Inc has advanced modestly in after-market trading, remaining significantly above its 20-day moving average and showing notable gains over the past month.

23 de set. de 2026, 20:07 UTC

Revvity Inc shares fell sharply, settling below Tuesday's close after an early peak, though remaining above the 20-day moving average.

22 de set. de 2026, 19:31 UTC

Revvity Inc shares fell sharply after briefly gaining earlier, but remain above their 20-day moving average and near the upper end of their one-month range.

21 de set. de 2026, 23:56 UTC

Revvity Inc is trading modestly higher in after-market hours, positioned above its 20-day moving average and near the upper end of its one-month range.

16 de set. de 2026, 20:07 UTC

Revvity Inc is trading higher, continuing a strong momentum with four consecutive sessions of gains and remaining well above its 20-day moving average.

15 de set. de 2026, 22:02 UTC

Revvity Inc. shares are lower in after-market trading, reflecting broader market trends amid economic concerns following a significant drop in the NY Empire State Manufacturing Index.

14 de set. de 2026, 20:08 UTC

Revvity Inc shares are higher in Monday's session, continuing a broader upward trend since Friday. The stock is above its 20-day moving average.

11 de set. de 2026, 20:08 UTC

News

Revvity Inc will acquire Human Cell Design to enhance its Life Sciences sector reach. Shares are rising today after five consecutive lower sessions.

Comparação entre Pares

Variação de preço

PerkinElmer Inc Previsão

Preço-alvo

By TipRanks

-14.26% parte inferior

Previsão para 12 meses

Média 141.75 USD  -14.26%

Máximo 175 USD

Mínimo 110 USD

Com base em 14 analistas de Wall Street que oferecem metas de preço de 12 meses para PerkinElmer Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

14 ratings

4

Comprar

10

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre PerkinElmer Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
help-icon Live chat